Literature DB >> 6329950

Mutant HLA-A2 antigens as restricting elements for virus-specific cytotoxic T cells.

J S Gaston, L E Wallace, A B Rickinson, M A Epstein, D Pious.   

Abstract

Mutants of the EB virus-transformed cell line T5-1 (HLA-A1, 2; B8, 27), bearing well-characterized alterations in HLA-A2 antigen expression and unable to bind the HLA-A2-specific monoclonal antibody BB7.2, have been tested for their susceptibility to EB virus-specific cytolysis using effector T-cell preparations functionally restricted through relevant HLA antigens. Initial experiments first confirmed that the parent line T5-1 was susceptible to cytolysis by both "common" A2-restricted and B27-restricted effector cells. While those T5-1 mutants with little or no surface A2 expression were not lysed by A2-restricted effectors, those targets with quantitatively normal expression of mutant A2 molecules were as susceptible to A2-restricted lysis as the parent line itself. In contrast, all the T5-1 mutant lines were susceptible to B27-restricted cytolysis. The results demonstrate that experimentally induced mutations of HLA-A2 antigen structure, affecting a serologically defined site on the molecule, can occur without altering that same molecule's expression of the T cell-restricting determinant(s). Such experimentally induced mutations are quite different from the naturally occurring "variant" A2 antigens which are present within the serologically defined A2 antigen group and which show changes at the T cell-restricting site.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6329950     DOI: 10.1007/bf00403438

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  29 in total

Review 1.  Monoclonal antibodies for analysis of the HLA system.

Authors:  F M Brodsky; P Parham; C J Barnstable; M J Crumpton; W F Bodmer
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

2.  Y-antigen killing by T cells of women is restricted by HLA.

Authors:  E Goulmy; A Termijtelen; B A Bradley; J J van Rood
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

3.  Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line.

Authors:  C F Ware; M S Krangel; D Pious; S J Burakoff; J L Strominger
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

4.  Comparative structural analysis of HLA-A2 antigens distinguishable by cytotoxic T lymphocytes: variants M7 and DR1.

Authors:  M S Krangel; S Taketani; W E Biddison; D M Strong; J L Strominger
Journal:  Biochemistry       Date:  1982-11-23       Impact factor: 3.162

5.  Human cell-mediated cytotoxicity against modified target cells is restricted by HLA.

Authors:  E Dickmeiss; B Soeberg; A Svejgaard
Journal:  Nature       Date:  1977-12-08       Impact factor: 49.962

6.  Monoclonal antibodies to Epstein-Barr virus-induced, transformation-associated cell surface antigens: binding patterns and effect upon virus-specific T-cell cytotoxicity.

Authors:  M Rowe; J E Hildreth; A B Rickinson; M A Epstein
Journal:  Int J Cancer       Date:  1982-04-15       Impact factor: 7.396

7.  Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro.

Authors:  D J Moss; L E Wallace; A B Rickinson; M A Epstein
Journal:  Eur J Immunol       Date:  1981-09       Impact factor: 5.532

8.  Loss of serological determinants does not affect recognition of H-2Kk target cells by an influenza-specific cytotoxic T cell clone.

Authors:  D C Wraith; B Holtkamp; B A Askonas
Journal:  Eur J Immunol       Date:  1983-09       Impact factor: 5.532

9.  Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinants.

Authors:  L E Wallace; D J Moss; A B Rickinson; A J McMichael; M A Epstein
Journal:  Eur J Immunol       Date:  1981-09       Impact factor: 5.532

10.  Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinants.

Authors:  J S Gaston; A B Rickinson; M A Epstein
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

View more
  5 in total

1.  Allospecific T cell recognition of HLA-A2 antigens: evidence for group-specific and subgroup-specific epitopes.

Authors:  L E Wallace; M A Houghton; A B Rickinson; M A Epstein; B A Bradley
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

2.  Characterization of the HLA-A2.2 subtype: T cell evidence for further heterogeneity.

Authors:  F M Gotch; C Kelly; S A Ellis; L Wallace; A B Rickinson; J van der Poel; M J Crumpton; A J McMichael
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

3.  New HLA-A2 variants defined by monoclonal antibodies and cytotoxic T lymphocytes.

Authors:  L J Kennedy; L E Wallace; J A Madrigal; A B Rickinson; J G Bodmer
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

4.  Refinement of HLA gene mapping with induced B-cell line mutants.

Authors:  B Spring; C Fonatsch; C Müller; G Pawelec; J Kömpf; P Wernet; A Ziegler
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

5.  HLA class II regulation and structure. Analysis with HLA-DR3 and HLA-DP point mutants.

Authors:  D Pious; L Dixon; F Levine; T Cotner; R Johnson
Journal:  J Exp Med       Date:  1985-10-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.